We have isolated several cDNA clones encoding 6-aminolevulinate dehydrase [ALAD; porphobilinogen synthase; 5-aminolevulinate hydro-lyase (adding 5-aminolevulinate and cyclizing), EC 4.2.1.24], the second enzyme in the heme biosynthetic pathway. We used a rabbit polyclonal antibody developed against the purified 35-kDa subunit of rat liver ALAD to screen a Xgtll cDNA expression library constructed from rat liver mRNA. A prototype clone (ALAD-1) contained a 680-base-pair insert and expressed a 140-kDa ,B-galactosidase gene cDNA insert fusion protein immunoreactive with both polyclonal and monoclonal anti-ALAD. Identity of ALAD-1 was verified by hydridization to ALAD mRNA that had been enriched via immunopurification of rat liver polysomes with anti-ALAD. Intensity of such hybridization to a 1500-nucleotide-long mRNA was m200-fold greater than that realized with whole liver mRNA, a result consistent with the degree of immunoenrichment of ALAD mRNA found independently by analysis of cell-free translation products. A second ALAD cDNA clone (ALAD-3) was isolated when the rat liver cDNA expression library was rescreened with ALAD-1. The identity of both ALAD cDNA clones was established by correspondence between their nucleotide sequence and the reported amino-terminal protein sequence of bovine ALAD. Hybridization of ALAD cDNA to mouse genomic DNA indicates that the previously unexplained incremental differences in ALAD enzymatic activity among inbred mouse strains has arisen through alterations in ALAD gene dose.
,B-galactosidase gene cDNA insert fusion protein immunoreactive with both polyclonal and monoclonal anti-ALAD. Identity of ALAD-1 was verified by hydridization to ALAD mRNA that had been enriched via immunopurification of rat liver polysomes with anti-ALAD. Intensity of such hybridization to a 1500-nucleotide-long mRNA was m200-fold greater than that realized with whole liver mRNA, a result consistent with the degree of immunoenrichment of ALAD mRNA found independently by analysis of cell-free translation products. A second ALAD cDNA clone (ALAD-3) was isolated when the rat liver cDNA expression library was rescreened with ALAD-1. The identity of both ALAD cDNA clones was established by correspondence between their nucleotide sequence and the reported amino-terminal protein sequence of bovine ALAD. Hybridization of ALAD cDNA to mouse genomic DNA indicates that the previously unexplained incremental differences in ALAD enzymatic activity among inbred mouse strains has arisen through alterations in ALAD gene dose. 8 -Aminolevulinate dehydrase [ALAD; porphobilinogen synthase; 5-aminolevulinate hydro-lyase (adding 5-aminolevulinate and cyclizing), EC 4.2. 1.24] , is the second enzyme in the heme biosynthetic pathway (1) . In this report, we describe the isolation of recombinant cDNA clones encoding rat liver ALAD. We have used one of these clones to examine the source of the roughly 3:2:1 incremental differences in ALAD enzyme level observed among inbred mouse strains (2, 3) . We find that different strains exhibit different doses ofALAD gene DNA in a way that parallels, and accounts for, the reported differences in ALAD enzyme activity.
MATERIALS AND METHODS Materials. Radiochemicals were obtained from New England Nuclear or Amersham, endonucleases were from Bethesda Research Laboratories, and reverse transcriptase was from Life Sciences (St. Petersburg, FL). DNA from individual mouse strains was purchased, as such, from The Jackson Laboratory. A plasmid bearing mouse adult ,B3globin cDNA (pCRlBM9) (4) and a plasmid bearing mouse carbonic anhydrase II cDNA (p6-69) (5) were gifts from M. Edgell (University of North Carolina) and P. Curtis (Wistar Institute), respectively. ALAD Purification. Liver cytosol from adult Wistar rats was prepared and fractionated with protamine sulfate as described by Nakakuki et al. (6) . ALAD, as judged by enzyme assay (7) , was precipitated by 50% saturation with (NH4)2SO4 from the fraction remaining soluble after 35% saturation. Thereafter, ALAD was resuspended in 6.8DP buffer (0.1 mM dithiothreitol/7 mM potassium phosphate, pH 6.8) and applied to a DE52 (Whatman) column equilibrated in 6.8DP. After washing with a large volume of 6.8DP containing 0.1 M KCl, ALAD was eluted at 250C by a linear KCl gradient (0.125-0.35 M) in 6.8DP. ALAD active fractions were precipitated by (NH4)2SO4, resuspended in 6.8DP buffer containing 0.5 M KCl, and applied to a Sephacryl S200 (Pharmacia) column (5 x 86 cm) equilibrated with the same solution at 4°C. The ALAD-bearing peak corresponded to a protein of =273 kDa. ALAD active S200 fractions were precipitated by (NH4)2SO4, resuspended in 6.5DP buffer (3 mM dithiothreitol/10 mM sodium phosphate, pH 6.5), and serially passaged three times through an IEX-545 DEAE (Beckman) HPLC column. The column and sample were equilibrated each time with 6.5DP buffer. Columns were all developed with a linear salt gradient, which contained 0.45 M NaCl end buffer, but ranged from 0.1 M to 0.25 M NaCl in starting buffers and from 12 ml to 30 ml in total volume. Fractions were examined by NaDodSO4/polyacrylamide gel electrophoresis and then by silver staining. When purified to homogeneity after the third IEX-545 passage, rat ALAD consisted of a single subunit of -35 kDa (35-kDa ALAD) i.e., like the ALAD subunit size found in other species (8) (9) (10) .
To ensure that ALAD to be used as immunogen was free of trace contaminants, the 35-kDa ALAD was isolated by electroelution (11, 12 (26) pALAD-1. Conditions for hybridization followed those described by Wahl et al. (28) except that dextran sulfate was omitted. Indicated nanograms of poly(A)+ mRNA present before and after R574 anti-35-kDa ALADmediated polysome purification were estimated by calibrated cellfree translation as described. Molecular sizes at left are based on ribosomal RNA standards. The minor slow-moving component seen in whole mRNA was presumably lost during polysome immunopurification.
reacted with rabbit anti-35-kDa ALAD (Fig. 1B) . The fusion protein also reacted with a mouse monoclonal antibody (33-4A) to the ALAD subunit (Fig. 1C) . The fusion peptide thus binds antibodies raised in two different species against highly purified 35-kDa ALAD, a result that minimized the chance that the ALAD-1 insert encodes anything but the ALAD subunit.
Hybridization of Cloned cDNA with ALAD mRNA from Unfractionated and Enriched Preparations. Two (23) . Untreated aliquots containing the denoted quantities of incorporated radiolabel reacted with either 5 ,g of R574 anti-ALAD (odd-numbered lanes) or 5 ,ug of normal rabbit IgG (even-numbered lanes). Thereafter, immunoprecipitates were formed by overnight reaction with goat anti-rabbit IgG (Cooper Biomedical). Washed immunoprecipitates were boiled and applied as shown. After electrophoresis, En3Hance (New England Nuclear)-treated gels were exposed to x-ray film at -85°C for 300 hr and later, as shown here, for 2700 hr. were deduced by hybridization with rat liver polysomal poly(A)+ RNA. First, as shown in Fig. 2 , 3P-labeled pALAD-1 hybridizes with RNA whose 1500-nucleotide length is appropriate for encoding 35-kDa ALAD protein.
Second, the intensity of hybridization with 400 ng of mRNA from unfractionated polysomes (lane 1) is similar to that realized with 2 ng of mRNA from immunopurified ALADbearing polysomes (lane 2). The several hundred-fold enrichment of ALAD mRNA thus estimated is much like that independently adduced (Fig. 3) after electrophoresis of washed immunoprecipitates formed from reactions of rabbit anti-ALAD and anti-antibody with known quantities of tritiated cell-free translates. Specifically, immunoprecipitates of cell-free translates developed from the "immunopurified'' mRNA used in Fig. 2 contain in the Fig. 3  autoradiograph a 35-kDa element (lanes 1 and 5) . This element is indistinguishable from authentic ALAD (lane 10) . No such element is seen in Fig. 3 when anti-ALAD is replaced with nonimmune rabbit IgG (lanes 2 and 6) and none was seen when unfractionated polysomal poly(A)+ rat liver mRNA (lanes 7 and 8) or rabbit reticulocyte mRNA (lanes 3 and 4) served as a template for cell-free translation. Since the quantity of radiolabeled protein subject to immunoprecipitation was 15-fold greater for lane 7 than for lane 1, since nothing is seen in lane 7, and since results equivalent to those HindIII digests of -5 /ig of whole genome DNA were separated, together with radiolabeled markers (not shown), by 0.8% agarose gel electrophoresis; transferred to nitrocellulose; and hybridized with 32P-labeled pALAD-1 DNA (106 dpm/ml) using conditions described in Fig. 2 . kb, Kilobases. Individual digests of DNA from each mouse strain were prepared for each analysis. Thereafter, a digest was either applied to one lane (analyses 2 and 4) or equal volumes were applied to multiple lanes (analyses 1 and 3) . Data in analyses 1 and 3 derive from single probing of each lane. In analyses 2 and 4, each lane was probed first with ALAD and then, as described in Fig. 6 legend, with carbonic anhydrase II (CA II). Probes consisted of pALAD-1, mouse adult P-globin cDNA, and mouse CA II cDNA. In each analysis, autoradiographic intensities of the entirety of each reactive band were assessed in a Coming model 760 densitometer. Band densities were then summed for each lane and the denoted between-strain ratios were calculated by reference to a digest of DNA from the other mouse strain assayed in an adjacent lane. *Mean of two parallel determinations. tOne determination.
in Fig. 3 were also seen in a shorter autoradiographic exposure (1/9th the time), it follows that the estimated level of ALAD mRNA in the enriched preparation (lane 1) is at least 135-fold greater than in the unfractionated one (lane 7). The fact that this minimal estimate of ALAD mRNA enrichment is like that realized by nucleic hybridization in Fig. 2 supports our contention that ALAD-1 encodes ALAD sequences.
Comparison of ALAD Amino Acid Sequences and M13 ALAD Nucleotide Sequences. Conclusive evidence for the identity of the overlapping M13 ALAD-1 and M13 ALAD-3 cDNA clones appears in Fig. 4 . As shown there, amino acid residues deduced from rat liver M13 ALAD-1 and M13 ALAD-3 nucleotide sequences exhibit 80% homology with the 44 amino acid residues of bovine liver ALAD described by Lingner and Kleinschmidt (29) .
ALAD Genomic DNA Sequences and Gene Dose Differences in Mice. As illustrated in Fig. 5 , rat liver ALAD cDNA readily reacts with genomic DNA from several species. The relative number of ALAD copies, however, differs between mouse strains. Four sets of densitometric analyses of autoradiographic intensities (Table 1) suggest that ALAD gene dose, when normalized by reference to either 3-globin or carbonic anhydrase II dose, is 2 to 3 times greater in DBA/2 mice than in C57BL/6 mice. Such findings are extended in Fig. 6 to Rsa I digests of DNA from six kinds of mice including five inbred strains and the B6D2 F1 hybrid from a C57BL/6 x DBA/2 cross. The ALAD gene dose differences between mouse samples in Fig. 6A are validated in Fig. 6B where the intensities in all samples became similar when the radiolabeled ALAD probe was dissociated and the samples were reprobed with 32P-labeled mouse carbonic anhydrase II cDNA. We interpret these results, like those in Table 1 , to mean that between-strain differences in ALAD gene dose are genuine, assuming that carbonic anhydrase II gene dose is constant among mice sampled. Further support for the authenticity ofALAD gene dose differences is evident in Fig.  6C . Here the normalized ratios for ALAD/carbonic anhydrase II autoradiographic intensities closely correspond to the average levels of hepatic ALAD enzyme activity calculated from the reports of Hutton Fig. 6C , it seems unlikely that they do so out ofproportion to the number of active ALAD genes present in each mouse strain.
As it turns out, we can eliminate one class of pseudogenes from further consideration. The class in question is the processed pseudogenes, which are thought to arise by the random reinsertion into the genome of cDNA copies of mRNA. The usual hallmark of processed pseudogenes is that they lack intervening sequences and are thereby foreshortened relative to genomic sequences from which they arose (32) . Consequently, if this process had figured ini generating the ALAD gene dose differences evident in Figs. 5 and 6 and in Table 1 , we would expect to have found differences in restriction patterns between strains. The fact is that all mouse samples in Fig. 6A 
